PITX2 and ovarian carcinoma: We showed that there was no significant change of PITX2 expression upon activation of Wnt/β-catenin activity in ovarian cancer cell lines, suggesting that the aberrant upregulation of PITX2 may be regulated in-dependently by canonical β-catenin pathway in ovarian cancer cells.